The association between statins and telomere shortening

References

• Istvan ES. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Am. Heart J. 144(6 Suppl.), S27–S32 (2002).
   Google Scholar
• Liao JK, Laufs U. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45, 89–118 (2005).
   Google Scholar
• Ludman A, Venugopal V, Yellon DM, Hausenloy DJ. Statins and cardioprotection – more than just lipid lowering? Pharmacol. Ther. 122, 30–43 (2009).
   Google Scholar
• Lardizabal JA, Deedwania P. Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease. Cardiol. Clin. 29(1), 87–103(2011).
   Google Scholar
• Ali BR, Nouvel I, Leung KF, Hume AN, Seabra MC. A novel statin-mediated ‘prenylation block-and-release’ assay provides insight into the membrane targeting mechanisms of small GTPases. Biochem. Biophys. Res. Commun. 397(1), 34–41 (2010).
   Google Scholar
• Davignon J, Laaksonen R. Low-density lipoproteinindependent effects of statins. Curr. Opin. Lipidol. 10(6), 543–559 (1999).
   Google Scholar
• Olivieri F, Mazzanti I, Abbatecola AM et al. Telomere/ telomerase system: a new target of statins pleiotropic effect? Curr. Vasc. Pharmacol. 10(2), 216–224 (2012).
   Google Scholar
• Tohru Minamino, Issei Komuro. Vascular cell senescence contribution to atherosclerosis. Circ. Res. 100, 15–26 (2007).
   Google Scholar
• Assmus B, Urbich C, Aicher A et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ. Res. 92(9), 1049–1055 (2003).
   Google Scholar
• Matthews C, Gorenne I, Scott S et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ. Res. 99(2), 156–164 (2006).
   Google Scholar
• Hayflick L. The cell biology of human aging. N. Engl. J. Med. 295 (23), 1302–1308 (1976).
   Google Scholar
• Herbig U, Sedivy JM. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech. Ageing Dev. 127, 16–24 (2006).
   Google Scholar
• Jeyapalan JC, Ferreira M, Sedivy JM, Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 128(1), 36–44 (2007).
   Google Scholar
• Campisi J, d’Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729–740 (2007).
   Google Scholar
• Shammas MA. Telomeres, lifestyle, cancer and aging. Curr. Opin. Clin. Nutr. Metab. Care 14, 28–34 (2011).
   Google Scholar
• Sfeir AJ, Chai W, Shay JW, Wright WE. Telomere end processing: the terminal nucleotides of human chromosomes. Mol. Cell. 18, 131–138 (2005).
   Google Scholar
• de Lange T. Protection of mammalian telomeres. Oncogene 21, 532–540 (2002).
   Google Scholar
• Cawthon RM, Smith KR, O’Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361, 393–395 (2003).
   Google Scholar
• Blackburn EH. Switching and signaling at the telomere. Cell 106, 661–673 (2001).
   Google Scholar
• Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015 (1994).
   Google Scholar
• Bodnar AG, Ouellette M, Frolkis M et al. Extension of lifespan by introduction of telomerase into normal human cells. Science 279, 349–352 (1998).
   Google Scholar
• Matthews C, Gorenne I, Scott S et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ. Res. 99(2), 156–164 (2006).
   Google Scholar
• Nakano-Kurimoto R, Ikeda K, Uraoka M et al. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. Am. J. Physiol. Heart Circ. Physiol. 297(5), H1673–H1684 (2009).
   Google Scholar
• Yokoi T, Fukuo K, Yasuda O et al. Apoptosis signalregulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cells. Diabetes 55(6), 1660–1665 (2006).
   Google Scholar
• Aviv A. Chronology vs biology: telomeres and the link between essential hypertension and vascular aging. Hypertension 40, 229–232 (2002).
   Google Scholar
• Jeanclos E, Schork NJ, Kyvik KO, Kimura M, Skurnick JH, Aviv A. Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension 36, 195–200 (2000).
   Google Scholar
• Benetos A, Okuda K, Lajemi M et al. Telomere length as an indicator of biologic aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 37, 381–385 (2001).
   Google Scholar
• Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet 358, 472–473 (2001).
   Google Scholar
• Satoh M, Ishikawa Y, Takahashi Y, Itoh T, Minami Y, Nakamura M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 198, 347–353 (2008).
   Google Scholar
• Puccetti L, Santilli F, Pasqui AL et al. Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. Atherosclerosis 214(1), 122–128 (2011).
   Google Scholar
• Chen JW, Zhou SB, Tan ZM. Aspirin and pravastatin reduce lectin-like oxidized low density lipoprotein receptor-1 expression, adhesion molecules and oxidative stress in human coronary artery endothelial cells. Chin. Med. J. (Engl.) 123(12), 1553–1556 (2010).
   Google Scholar
• Satoh M, Minami Y, Takahashi Y, Tabuchi T, Itoh T, Nakamura M. Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease. Clin. Sci. (Lond.) 116(11), 827–835 (2009).
   Google Scholar
• Saliques S, Teyssier JR, Vergely C et al. Circulating leukocyte telomere length and oxidative stress: a new target for statin therapy. Atherosclerosis 219(2), 753–760 (2012).
   Google Scholar
• Boccardi V, Barbieri M, Rizzo MR et al. A new pleiotropic effect of statins in elderly: modulation of telomerase activity. FASEB J. 27(9), 3879–3885 (2013). ▪▪ Shows, For The First Time, That Statin Use Correlates With Higher Telomerase Activity, Suggesting That These Drugs May Also Slow Down The Process Of Human Aging.
   Google Scholar
• Haendeler J, Hoffmann J, Diehl JF et al. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ. Res. 94(6), 768–775 (2004).
   Google Scholar
• Spyridopoulos I, Haendeler J, Urbich C et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 110(19), 3136–3142 (2004). ▪▪ Describes A Beneficial Effect Of Statins On Telomere Biology.
   Google Scholar
• Brouilette SW, Moore JS, McMahon AD et al. West of Scotland Coronary Prevention Study Group. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 369(9556), 107–114 (2007).
   Google Scholar